Activity

Activity ID

3674

Expires

June 18, 2023

Format Type

Enduring

CME Credit

0.75

Fee

$20
CME Provider

American Medical Association

Description

In this course you will learn about trends on current and projected prescription drug spending, Medicare Part D prescription drug coverage, projected drug spending, public opinion on drug costs and proposed controls, biologics and biosimilars, cancer drugs, and drug shortages.

Disclaimers
1. This activity is hosted on the AMA Ed Hub.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

1. Identify current trends in drug spending, biologics, biosimilars, cancer drugs and drug shortages
2. Define causes of, and efforts taken, to mitigate the rising costs of prescription drugs and drug shortages
3. Explain predicted impacts of drug spending and drug shortage trends for patients, physicians, payers and policymakers

Keywords

Health Care Economics, Insurance, Payment, Pharmacoeconomics

Competencies

Systems-based Practice

CME Credit Type

AMA PRA Category 1 Credit

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.